Targeting the proline–glutamine–asparagine–arginine metabolic axis in amino acid starvation cancer therapy

Macus Tien Kuo, Helen H.W. Chen, Lynn G. Feun, Niramol Savaraj

研究成果: Review article同行評審

11 引文 斯高帕斯(Scopus)

摘要

Proline, glutamine, asparagine, and arginine are conditionally non-essential amino acids that can be produced in our body. However, they are essential for the growth of highly proliferative cells such as cancers. Many cancers express reduced levels of these amino acids and thus require import from the environment. Meanwhile, the biosynthesis of these amino acids is inter-connected but can be intervened individually through the inhibition of key enzymes of the biosynthesis of these amino acids, resulting in amino acid starvation and cell death. Amino acid starvation strategies have been in various stages of clinical applications. Targeting asparagine using asparaginase has been approved for treating acute lymphoblastic leukemia. Targeting glutamine and arginine starvations are in various stages of clinical trials, and targeting proline starvation is in preclinical development. The most important obstacle of these therapies is drug resistance, which is mostly due to reactivation of the key enzymes involved in biosynthesis of the targeted amino acids and reprogramming of compensatory survival pathways via transcriptional, epigenetic, and post-translational mechanisms. Here, we review the interactive regulatory mechanisms that control cellular levels of these amino acids for amino acid starvation therapy and how drug resistance is evolved underlying treatment failure.

原文English
文章編號72
頁(從 - 到)1-20
頁數20
期刊Pharmaceuticals
14
發行號1
DOIs
出版狀態Published - 2021 1月

All Science Journal Classification (ASJC) codes

  • 分子醫學
  • 藥學科學
  • 藥物發現

指紋

深入研究「Targeting the proline–glutamine–asparagine–arginine metabolic axis in amino acid starvation cancer therapy」主題。共同形成了獨特的指紋。

引用此